Edwards Lifesciences CVP Daniel Lippis sells $34,382 in stock
Daniel J. Lippis, the Corporate Vice President for JAPAC at Edwards Lifesciences Corp (NYSE:EW), has disclosed recent stock ...
Wolfe Research cuts Edwards Lifesciences stock rating to Underperform
Wolfe Research adjusted its perspective on Edwards Lifesciences (NYSE:EW) shares, downgrading its rating from Peerperform to ...
Edwards Lifesciences downgraded at Wolfe on TAVR worries
Edwards Lifesciences (EW) stock faces a downgrade at Wolfe due to concerns over its TAVR market prospects. Read more here.
Edwards Lifesciences downgraded to Underperform at Wolfe Research
Wolfe Research downgraded Edwards Lifesciences (EW) to Underperform from Peer Perform with a $60 price target The firm says its core ...
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day
This was the stock's fourth consecutive day of losses.